1. Home
  2. RYN vs GRFS Comparison

RYN vs GRFS Comparison

Compare RYN & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Inc. REIT

RYN

Rayonier Inc. REIT

HOLD

Current Price

$20.46

Market Cap

6.4B

Sector

Real Estate

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.08

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYN
GRFS
Founded
1926
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.5B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
RYN
GRFS
Price
$20.46
$8.08
Analyst Decision
Buy
Hold
Analyst Count
4
2
Target Price
$26.00
$10.15
AVG Volume (30 Days)
1.9M
580.9K
Earning Date
05-06-2026
07-28-2022
Dividend Yield
11.73%
1.80%
EPS Growth
26.78
N/A
EPS
3.03
N/A
Revenue
$484,485,000.00
N/A
Revenue This Year
$214.97
$4.49
Revenue Next Year
$10.35
$6.42
P/E Ratio
$6.78
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$19.49
$7.10
52 Week High
$27.34
$11.14

Technical Indicators

Market Signals
Indicator
RYN
GRFS
Relative Strength Index (RSI) 41.96 46.08
Support Level $19.49 $7.87
Resistance Level $21.68 $8.88
Average True Range (ATR) 0.48 0.20
MACD -0.08 -0.01
Stochastic Oscillator 11.62 36.13

Price Performance

Historical Comparison
RYN
GRFS

About RYN Rayonier Inc. REIT

Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: